Tigeciklin (Serbian Wikipedia)
Analysis of information sources in references of the Wikipedia article "Tigeciklin" in Serbian language version.
refsWebsite
Global rank
Serbian rank
6th place
5th place
719th place
468th place
archive.org
- Rose W, Rybak M (2006). „Tigecycline: first of a new class of antimicrobial agents.”. Pharmacotherapy. 26 (8): 1099—110. PMID 16863487. doi:10.1592/phco.26.8.1099.
doi.org
- Rose W, Rybak M (2006). „Tigecycline: first of a new class of antimicrobial agents.”. Pharmacotherapy. 26 (8): 1099—110. PMID 16863487. doi:10.1592/phco.26.8.1099.
- N, Kasbekar (2006). „Tigecycline: a new glycylcycline antimicrobial agent.”. Am J Health Syst Pharm. 63 (13): 1235—43. PMID 16790575. doi:10.2146/ajhp050487.
- Projan, Steven J (2010). „Francis Tally and the discovery and development of tigecycline: a personal reminiscence”. Clin. Infect. Dis. United States. 50 Suppl 1: S24—5. PMID 20067389. doi:10.1086/647941.
- Kumarasamy et. al.; Toleman, Mark A; Walsh, Timothy R; Bagaria, Jay; Butt, Fafhana; Balakrishnan, Ravikumar; Chaudhary, Uma; Doumith, Michel; Giske, Christian G (2010). „Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological study”. The Lancet Infectious Diseases. 10 (9): 597—602. PMC 2933358
. PMID 20705517. doi:10.1016/S1473-3099(10)70143-2. - Betriu C, Rodríguez-Avial I, Sánchez BA, Gómez M, Picazo JJ (2002). „Comparative in vitro activities of tigecycline (GAR-936) and other antimicrobial agents against Stenotrophomonas maltophilia”. J Antimicrob Chemother. 50 (5): 758–59. PMID 12407139. doi:10.1093/jac/dkf196.
medscape.com
- Tigecycline: A Novel Broad-Spectrum Antimicrobial: Pharmacology and Mechanism of Action Christine M. Slover, PharmD, Infectious Diseases Fellow, Keith A. Rodvold, PharmD and Larry H. Danziger, PharmD, Professor, Department of Pharmacy Practice, University of Illinois at Chicago, Chicago, IL
nih.gov
ncbi.nlm.nih.gov
- Rose W, Rybak M (2006). „Tigecycline: first of a new class of antimicrobial agents.”. Pharmacotherapy. 26 (8): 1099—110. PMID 16863487. doi:10.1592/phco.26.8.1099.
- N, Kasbekar (2006). „Tigecycline: a new glycylcycline antimicrobial agent.”. Am J Health Syst Pharm. 63 (13): 1235—43. PMID 16790575. doi:10.2146/ajhp050487.
- Projan, Steven J (2010). „Francis Tally and the discovery and development of tigecycline: a personal reminiscence”. Clin. Infect. Dis. United States. 50 Suppl 1: S24—5. PMID 20067389. doi:10.1086/647941.
- Kumarasamy et. al.; Toleman, Mark A; Walsh, Timothy R; Bagaria, Jay; Butt, Fafhana; Balakrishnan, Ravikumar; Chaudhary, Uma; Doumith, Michel; Giske, Christian G (2010). „Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological study”. The Lancet Infectious Diseases. 10 (9): 597—602. PMC 2933358 . PMID 20705517. doi:10.1016/S1473-3099(10)70143-2.
- Betriu C, Rodríguez-Avial I, Sánchez BA, Gómez M, Picazo JJ (2002). „Comparative in vitro activities of tigecycline (GAR-936) and other antimicrobial agents against Stenotrophomonas maltophilia”. J Antimicrob Chemother. 50 (5): 758–59. PMID 12407139. doi:10.1093/jac/dkf196.